Back
Regulus Therapeutics Stock Predictions
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
55
RGLS
Regulus Therapeutics
Last Price:
$8.22
Seasonality Move:
-22.72%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.Regulus Therapeutics Stock Forecast
-
Over the next 52 weeks, Regulus Therapeutics has on average historically fallen by 3.8% based on the past 12 years of stock performance.
-
Regulus Therapeutics has fallen lower in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Regulus Therapeutics Stock Undervalued?The current Regulus Therapeutics [RGLS] share price is $8.21. The Score for RGLS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RGLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Regulus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Regulus Therapeutics has on average historically fallen by 3.8% based on the past 12 years of stock performance.
Regulus Therapeutics Stock Rating
Buy
55
Regulus Therapeutics (RGLS)
is a Buy
Is Regulus Therapeutics overpriced?
-
Regulus Therapeutics has fallen lower in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Regulus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regulusrx.com
52-Week Data
52-Week High:
8.35
52-Week Low:
0.83
Prediction Charts
Market Cap:
568.4M
Price in USD:
8.21
Volume:
1.4M
Beta:
1.23
Technical Analysis
SMA50:
6.26
SMA100:
3.81
SMA200:
2.67
52-Wk Change:
231.05%
Stock Predictions
-
Is Regulus Therapeutics stock public?Yes, Regulus Therapeutics is a publicly traded company.
-
What is the Regulus Therapeutics stock quote today?The Regulus Therapeutics stock price is 8.21 USD today.
-
How to buy Regulus Therapeutics stock online?You can buy Regulus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-30 | 7.93 | 7.93 | 7.95 | 7.91 |
| Jun-2 | 7.93 | 7.94 | 7.98 | 7.91 |
| Jun-3 | 7.98 | 7.97 | 7.99 | 7.94 |
| Jun-4 | 7.95 | 7.95 | 7.99 | 7.94 |
| Jun-5 | 8.00 | 8.10 | 8.13 | 7.98 |
| Jun-6 | 8.12 | 8.22 | 8.28 | 8.07 |
| Jun-9 | 8.23 | 8.30 | 8.35 | 8.22 |
| Jun-10 | 8.28 | 8.30 | 8.31 | 8.22 |
| Jun-11 | 8.31 | 8.15 | 8.32 | 8.15 |
| Jun-12 | 8.10 | 8.08 | 8.15 | 8.06 |
| Jun-13 | 8.05 | 8.11 | 8.12 | 8.03 |
| Jun-16 | 8.20 | 8.22 | 8.28 | 8.07 |
| Jun-17 | 8.20 | 8.20 | 8.24 | 8.16 |
| Jun-18 | 8.20 | 8.21 | 8.29 | 8.17 |
Regulus Therapeutics Earnings
Regulus Therapeutics Earnings Report: Per Share Regulus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regulus Therapeutics Forecast Revenue Growth
Regulus Therapeutics Stock Analysis: Historical quarterly revenues per share for Regulus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.09 per share, and a decrease next year of $0.22 per share.
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.